Summary
The country’s diverse disease environment gives scientists a unique chance to study many germs and develop new medicines.
Partnerships with the Coalition for Epidemic Preparedness Innovations and the Department of Biotechnology support advanced vaccine research and training.
Recent achievements include India’s first messenger RNA COVID‑19 vaccine and new candidates for diseases such as chikungunya, monkeypox and broad‑spectrum coronavirus protection.
Ongoing efforts aim to build stronger infrastructure, expand next‑generation vaccine platforms, and improve global health security.